Clinical Trial Update: HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the feasibility of high-dose accelerated conformal radiotherapy for non-small cell lung cancer; the trial has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Non-Small-Cell Lung Carcinoma | Phase 1, Phase 2 | Status: COMPLETED